D-0074-2027 Class II Ongoing

Recalled by Glenmark Pharmaceuticals Inc., USA — Elmwood Park, NJ

FDA drug recall D-0074-2027 was initiated by Glenmark Pharmaceuticals Inc., USA on Oct 9, 2026 and is designated Class II. Reason for recall: Labeling: Not Elsewhere Classified The recall status is ongoing. Affected quantity: 1296 bottles.

Recall details

Product Type
Drugs
Report Date
Nov 4, 2026
Initiation Date
Oct 9, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1296 bottles

Product description

Abiraterone Acetate Tablets USP 500 mg, 60-count bottles, Rx only, Distributed by: Glenmark Pharmaceuticals USA, Elmwood Park, NJ 07407, NDC 68462-882-60

Reason for recall

Labeling: Not Elsewhere Classified

Distribution pattern

Nationwide within the United States

Code information

Lot #: 13250135, Exp. Date 11/2027

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0074-2027
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0074-2027. Report a data issue: hello@regdatalab.com.